Eligible patients—typically aged ≤70 years, with NT-proBNP <5,000 pg/mL, systolic blood pressure >90 mmHg, and no severe autonomic neuropathy—may proceed to autologous stem cell transplantation (ASCT) to enhance long-term survival. Here, NPPB is linked to autonomic neuropathy.